BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,029 filers reported holding BAXTER INTL INC in Q4 2014. The put-call ratio across all filers is 0.83 and the average weighting 0.5%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $241,000 | -24.0% | 2,858 | -60.0% | 0.01% | -54.5% |
| Q4 2016 | $317,000 | -87.2% | 7,144 | -86.2% | 0.01% | -87.8% |
| Q3 2016 | $2,470,000 | +644.0% | 51,886 | +606.3% | 0.09% | +592.3% |
| Q2 2016 | $332,000 | -19.4% | 7,346 | -26.7% | 0.01% | -23.5% |
| Q1 2016 | $412,000 | +11.7% | 10,027 | +3.6% | 0.02% | +6.2% |
| Q4 2015 | $369,000 | -10.0% | 9,681 | -22.4% | 0.02% | -11.1% |
| Q3 2015 | $410,000 | -97.3% | 12,481 | -94.1% | 0.02% | -96.8% |
| Q2 2015 | $14,913,000 | -78.2% | 213,255 | -78.6% | 0.56% | -77.2% |
| Q1 2015 | $68,418,000 | -13.0% | 998,806 | -7.0% | 2.48% | -10.7% |
| Q4 2014 | $78,686,000 | +1.7% | 1,073,621 | -0.4% | 2.77% | -0.6% |
| Q3 2014 | $77,381,000 | +5.8% | 1,078,187 | +6.6% | 2.79% | +7.8% |
| Q2 2014 | $73,158,000 | -3.4% | 1,011,868 | -1.7% | 2.59% | -5.9% |
| Q1 2014 | $75,706,000 | +14.6% | 1,028,892 | +8.3% | 2.75% | +13.5% |
| Q4 2013 | $66,089,000 | +9.0% | 950,238 | +3.0% | 2.42% | +0.8% |
| Q3 2013 | $60,617,000 | -1.6% | 922,773 | +3.8% | 2.40% | -5.6% |
| Q2 2013 | $61,576,000 | – | 888,933 | – | 2.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
| SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
| Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
| Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
| HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
| Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
| 13D Management LLC | 200,318 | $14,791,000 | 3.77% |
| ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
| Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |